X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (38) 38
humans (31) 31
hematology (24) 24
animals (17) 17
systemic mastocytosis (17) 17
cell line, tumor (15) 15
female (15) 15
male (15) 15
apoptosis - drug effects (13) 13
oncology (13) 13
protooncogene c-kit (13) 13
aged (12) 12
mastocytosis (12) 12
adult (11) 11
c-kit (11) 11
mast cells - pathology (11) 11
middle aged (11) 11
proto-oncogene proteins c-kit - genetics (10) 10
tyrosine kinase inhibitors (10) 10
activating mutation (9) 9
article (9) 9
cell proliferation - drug effects (9) 9
chronic myelogenous leukemia (9) 9
dogs (9) 9
mutation (9) 9
proto-oncogene proteins c-kit - metabolism (9) 9
chronic myeloid-leukemia (8) 8
classification (8) 8
drug synergism (8) 8
mast cells - metabolism (8) 8
wild-type (8) 8
cancer (7) 7
imatinib (7) 7
immunology (7) 7
kit (7) 7
mast cells - drug effects (7) 7
medicine, research & experimental (7) 7
of-the-art (7) 7
catalytic domain (6) 6
dasatinib (6) 6
drug resistance (6) 6
growth (6) 6
identification (6) 6
leukemia (6) 6
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (6) 6
mast cell disease (6) 6
mast-cells (6) 6
mastocytosis, systemic - drug therapy (6) 6
mastocytosis, systemic - genetics (6) 6
mice (6) 6
staurosporine - analogs & derivatives (6) 6
abridged index medicus (5) 5
apoptosis (5) 5
dasatinib bms-354825 (5) 5
flow cytometry (5) 5
hemic and lymphatic diseases (5) 5
in-vitro (5) 5
mastocytosis, systemic - metabolism (5) 5
pkc412 (5) 5
protein kinase inhibitors - pharmacology (5) 5
pyrimidines - pharmacology (5) 5
response criteria (5) 5
veterinary sciences (5) 5
acute myeloid-leukemia (4) 4
advanced basic science (4) 4
aged, 80 and over (4) 4
allergy (4) 4
chronic-phase (4) 4
cml (4) 4
dog diseases - drug therapy (4) 4
dose-response relationship, drug (4) 4
drug resistance, neoplasm - drug effects (4) 4
esophageal cancer (4) 4
gastroenterology & hepatology (4) 4
hematology, oncology and palliative medicine (4) 4
kinases (4) 4
mast cells (4) 4
mastocytoma - drug therapy (4) 4
mastocytosis, systemic - pathology (4) 4
medicine & public health (4) 4
mice, inbred nod (4) 4
mutations (4) 4
patient outcomes (4) 4
protein kinase inhibitors - adverse effects (4) 4
research (4) 4
staurosporine - pharmacology (4) 4
stem cells (4) 4
tumors (4) 4
tyrosine (4) 4
tyrosine kinase (4) 4
tyrosine kinase inhibitor (4) 4
activation (3) 3
antineoplastic agents - pharmacology (3) 3
antineoplastic agents - therapeutic use (3) 3
arterial occlusive disease (3) 3
bcr-abl (3) 3
bone-marrow (3) 3
development and progression (3) 3
drug screening assays, antitumor (3) 3
fc-epsilon-ri (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Leukemia, ISSN 0887-6924, 11/2017, Volume 31, Issue 11, pp. 2388 - 2397
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2012, Volume 7, Issue 1, p. e29925
The phosphoinositide 3-kinase (PI3-kinase) and the mammalian target of rapamycin (mTOR) are two major signaling molecules involved in growth and activation of... 
SURVIVAL | HUMAN-BLOOD BASOPHILS | FC-EPSILON-RI | MASTOCYTOSIS | TYROSINE KINASE | MULTIDISCIPLINARY SCIENCES | C-KIT | RECEPTOR | RECOMBINANT ALLERGENS | HISTAMINE-RELEASE | EXPRESSION | Humans | Middle Aged | Male | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Quinolines - pharmacology | TOR Serine-Threonine Kinases - antagonists & inhibitors | Immunoglobulin E - immunology | Basophils - immunology | Aged, 80 and over | Adult | Female | Basophils - drug effects | Mast Cells - immunology | Molecular Targeted Therapy - adverse effects | Imidazoles - adverse effects | Immunoglobulin E - metabolism | Immunoglobulin E - pharmacology | Imidazoles - pharmacology | Down-Regulation - drug effects | Mast Cells - drug effects | Xenograft Model Antitumor Assays | Animals | Mice, Nude | Cell Line, Tumor | Aged | Cell Proliferation - drug effects | Mice | Immunoglobulin E - physiology | Antibody-Dependent Cell Cytotoxicity - drug effects | Quinolines - adverse effects | Immunoglobulin E | Histamine | Growth | Apoptosis | TOR protein | Allergens | Thoracic surgery | Laboratories | Leukemia | Oncology | Activation | Thymidine | Kinases | Veterinary medicine | Signal transduction | Cell activation | Immunology | Xenografts | Bone marrow | Drug dosages | Internal medicine | Hematology | CD63 antigen | Pharmacology | Rapamycin | Allergies | 1-Phosphatidylinositol 3-kinase | Signaling | Infectious diseases | Stem cells | Ligands | Mast cells | Leukocytes (basophilic) | Cancer
Journal Article
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 11/2015, Volume 29, Issue 11, pp. 2230 - 2237
Journal Article
Leukemia, ISSN 0887-6924, 04/2018, Volume 32, Issue 4, pp. 1016 - 1022
Systemic mastocytosis (SM) is a mast cell (MC) neoplasm with complex pathology and a variable clinical course. In aggressive SM (ASM) and MC leukemia (MCL),... 
TARGET | ACTIVATING MUTATION | PROTOONCOGENE C-KIT | ONCOLOGY | ADVANCED SYSTEMIC MASTOCYTOSIS | GROWTH | LINE | CLASSIFICATION | LEUKEMIA | IDENTIFICATION | HEMATOLOGY | AURORA KINASE INHIBITORS | Apoptosis - drug effects | Humans | Middle Aged | Male | Staurosporine - analogs & derivatives | Norbornanes - pharmacology | Proto-Oncogene Proteins c-kit - metabolism | Young Adult | STAT5 Transcription Factor - metabolism | G2 Phase Cell Cycle Checkpoints - drug effects | Mast Cells - metabolism | Mastocytosis, Systemic - metabolism | Aged, 80 and over | Adult | Female | Phosphorylation - drug effects | Leukemia, Mast-Cell - drug therapy | Tumor Suppressor Proteins - metabolism | Mastocytosis, Systemic - drug therapy | Pyrimidines - pharmacology | Mast Cells - drug effects | Dasatinib - pharmacology | Drug Synergism | Animals | Cell Cycle Checkpoints - drug effects | Dogs | Cell Line, Tumor | Aged | Leukemia, Mast-Cell - metabolism | Protein Kinase Inhibitors - pharmacology | Staurosporine - pharmacology | Drug Resistance, Neoplasm - drug effects | Prevention | Transcription factors | Mast cell disease | Care and treatment | Enzyme inhibitors | Oncology, Experimental | Development and progression | Research | Drug resistance | Health aspects | Cancer | Tyrosine | Mastocytosis | Phosphorylation | Leukemia | AKT protein | Stat5 protein | Kinases | Bruton's tyrosine kinase | Inhibitors | Medical prognosis | Cell cycle | Mast cells | Inhibition | Apoptosis
Journal Article
The Thoracic and Cardiovascular Surgeon, ISSN 0171-6425, 10/2019, Volume 67, Issue 7, pp. 589 - 596
Abstract Background  The incidence of esophageal carcinoma is increasing in the western world, and esophageal resection is the essential therapy. Several... 
Original Thoracic
Journal Article
The Thoracic and Cardiovascular Surgeon, ISSN 0171-6425, 08/2018, Volume 66, Issue 5, pp. 404 - 406
Abstract Robotic-assisted surgery is rapidly increasing, especially in general surgery. It has been shown for years that the minimal invasive esophagectomy... 
How to Do It | da Vinci Xi | RAMIE | robotic esophagectomy | robotic MIE | esophageal cancer | esophagus | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | RESPIRATORY SYSTEM
Journal Article
Journal of International Medical Research, ISSN 0300-0605, 2/2019, Volume 47, Issue 2, pp. 1025 - 1029
We report a case of a 69-year-old patient with esophageal cancer and severe upper gastrointestinal bleeding during neoadjuvant radiochemotherapy who required... 
gastric conduit | Robotic surgery | Ivor–Lewis esophagectomy | esophageal cancer | real-time fluoroscopy | gastrointestinal bleeding | Ivor-Lewis esophagectomy | MEDICINE, RESEARCH & EXPERIMENTAL | PHARMACOLOGY & PHARMACY | Case Reports
Journal Article
DISEASES OF THE ESOPHAGUS, ISSN 1120-8694, 06/2019, Volume 32, Issue 6
Delayed gastric emptying (DGE) after Ivor-Lewis esophagectomy occurs postoperatively in up to 50% of the patients. This pyloric dysfunction can lead to severe... 
gastric pull-up | PYLOROPLASTY | DRAINAGE | Ivor-Lewis | RECONSTRUCTION | REFLUX | pneumatic dilatation | GASTROENTEROLOGY & HEPATOLOGY | gastric emptying | minimally invasive esophagectomy | CANCER | STOMACH
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2014, Volume 9, Issue 1, pp. e84417 - e84417
Malignant melanoma is a life-threatening skin cancer increasingly diagnosed in the western world. In advanced disease the prognosis is grave. Growth and... 
INITIATING CELLS | SURVIVAL | CUTANEOUS MALIGNANT-MELANOMA | MULTIDISCIPLINARY SCIENCES | GROWTH | THERAPIES | KINASES | Neoplasm Transplantation | Receptor, Epidermal Growth Factor - genetics | Receptor, Nerve Growth Factor - genetics | Humans | Gene Expression Regulation, Neoplastic | Male | Antigens, CD - genetics | Receptors, Erythropoietin - genetics | Antigens, CD - metabolism | Receptor, Epidermal Growth Factor - metabolism | Flow Cytometry | Melanoma - genetics | Proto-Oncogene Proteins c-kit - deficiency | Female | Proto-Oncogene Proteins c-kit - genetics | Receptor, Nerve Growth Factor - metabolism | Melanoma - metabolism | Skin Neoplasms - pathology | Programmed Cell Death 1 Receptor - metabolism | Immunophenotyping | Melanoma - pathology | Skin Neoplasms - metabolism | Animals | Skin Neoplasms - genetics | Cell Line, Tumor | Mice, Inbred NOD | Mice | Receptor, ErbB-4 | Receptors, Erythropoietin - metabolism | Programmed Cell Death 1 Receptor - genetics | Antigens | Prognosis | Cytokines | Erythropoietin | Melanoma | Nerve growth factor | Skin | B cells | Metastasis | Comparative analysis | Skin cancer | Drugs | Biotechnology | Flow cytometry | Transformation | Disease | PD-1 protein | Insulin-like growth factor I | Cytokine receptors | Melanocytes | Oncology | Insulin-like growth factors | Kinases | Veterinary medicine | Cancer therapies | Cell surface | CD45 antigen | Metastases | MDR1 protein | Receptors | CD44 antigen | Lesions | Growth factors | Subpopulations | Interleukin 2 receptors | Hematology | Intercellular adhesion molecule 1 | CD63 antigen | Dermatology | ErbB-3 protein | Patients | ErbB-2 protein | Studies | Cytometry | Antigen (tumor-associated) | Medical prognosis | Cell lines | Phenotyping | Stem cells | CD20 antigen | Cancer | Index Medicus
Journal Article